The Company paid dividends totaling $5.0 million and $4.1 million in the three months ended August 1, 2020 and July 27, 2019, respectively. Dividends paid in the three months ended August 1, 2020 include $0.9 million of dividends on restricted stock that vested during the period.

Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. A summary of changes in accumulated other comprehensive income (loss), net of tax is shown below:

	Three Months Ended
(Dollars in Millions)	August 1, 2020			July 27, 2019
Currency Translation Adjustments:
Balance at Beginning of Year	$	(25.9	)	$	(13.6	)
Other Comprehensive Income (Loss) Recognized During the Period, Net of Tax		20.3			(1.6	)
Balance at End of Period		(5.6	)		(15.2	)

Derivative Instruments:
Balance at Beginning of Year		(1.0	)		—
Other Comprehensive Loss Recognized During the Period, Net of Tax		(3.6	)		—
Balance at End of Period		(4.6	)		—

Accumulated Other Comprehensive Loss, End of Period	$	(10.2	)	$	(15.2	)

The Company has granted stock options, restricted stock awards (“RSAs”), restricted stock units (“RSUs”) and stock awards to employees and non-employee directors under the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (“2014 Plan”), the Methode Electronics, Inc. 2010 Stock Plan (“2010 Plan”), the Methode Electronics, Inc. 2007 Stock Plan (“2007 Plan”) and the Methode Electronics, Inc. 2004 Stock Plan (“2004 Plan”). The Company can no longer make grants under the 2010 Plan, 2007 Plan and 2004 Plan. The number of shares of common stock originally authorized under the 2014 Plan is 3,000,000. As of August 1, 2020, there was 2,051,588 shares available for award under the 2014 Plan.

RSUs granted under the 2014 Plan vest over a pre-determined period of time, generally between three to five years from the date of grant. The fair value of the RSUs are based on the closing stock price on the date of grant. As of August 1, 2020, there were 3,100 RSUs outstanding.

Under the various stock plans, common stock underlying vested RSUs held by certain executives will not be delivered until termination of employment or a change of control of the Company. As of August 1, 2020, common stock to be delivered to these executives totaled 577,055.

In the three months ended August 1, 2020 and July 27, 2019, the Company granted 33,000 shares and 30,000 shares, respectively, of common stock to its non-employee directors under the 2014 Plan. The shares vested immediately upon grant. The fair value was determined based on the closing price of the Company’s stock on the date of grant.

The following table summarizes combined stock option activity under the 2010 Plan and 2007 Plan:

	Shares			Wtd. Avg. Exercise Price
Outstanding and Exercisable at May 2, 2020		106,668		$	35.76
Exercised		(5,000	)	$	10.55
Forfeited		—		$	—
Outstanding and Exercisable at August 1, 2020		101,668		$	37.01

All stock-based awards to employees and non-employee directors are recognized in selling and administrative expenses on the condensed consolidated statements of income.

The table below summarizes the stock-based compensation expense related to the equity awards:

	Three Months Ended
(Dollars in Millions)	August 1, 2020		July 27, 2019
RSAs	$	—	$	1.2
RSUs		—		0.4
Director Awards		0.9		0.9
Total Stock-based Compensation Expense	$	0.9	$	2.5